Sanofi buys US haemophilia treatment firm for $11.6 bn
French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for...
from Articles | Mail Online http://ift.tt/2n2jSnV
via IFTTT http://ift.tt/2n2jSnV French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for... http://ift.tt/eA8V8J
from Articles | Mail Online http://ift.tt/2n2jSnV
via IFTTT http://ift.tt/2n2jSnV French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for... http://ift.tt/eA8V8J
Sanofi buys US haemophilia treatment firm for $11.6 bn
Reviewed by Michael
on
Monday, January 22, 2018
Rating:
No comments: